Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB: Safety Overview

Metric TACROLIMUS\TACROLIMUS ANHYDROUS TAFASITAMAB
Total FAERS Reports 6,814 1,392
Deaths Reported 888 475
Death Rate 13.0% 34.1%
Hospitalizations 2,610 433
Average Patient Age 48.1 yrs 70.0 yrs
% Female Patients 48.0% 50.1%
Manufacturer N/A Incyte Corporation
Route N/A INTRAVENOUS